Capital International Investors
Source: SEC Form 13F · as of Mar 2026Capital International Investors holds 9 biotech & pharma companies tracked by BioSniper, totaling $2.58B in value as of Mar 2026 (SEC Form 13F).
Companies held
9
Total value held
$2.58B
BioSniper AIPage evidence connected
Prepared research question
What matters most for BeOne Medicines Ltd. (ONC)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ONCBeOne Medicines Ltd. | 4,158,726 | $1.23B |
| INSMINSMED Inc | 5,595,194 | $914.9M |
| CYTKCYTOKINETICS INC | 1,338,803 | $88.2M |
| SYRESpyre Therapeutics, Inc. | 1,746,129 | $88.1M |
| TEVATeva Pharmaceutical Industries Limited | 2,823,274 | $85.0M |
| TERNTerns Pharmaceuticals, Inc. | 1,424,504 | $75.1M |
| ZBIOZenas BioPharma, Inc. | 2,434,000 | $47.6M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 1,441,131 | $46.1M |
| AGIOAGIOS PHARMACEUTICALS, INC. | 48,616 | $1.6M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.